The firm AstraZeneca has concluded deals for 400 million doses of their AZD1222 vaccine currently being developed within Oxford University with plans to release it in September this year. The company said that it is capable of producing over one billion doses of the AZD1222 vaccine for this year and the next.
Already, initial trials are underway and the firm has already recognized that the potential vaccine may not work. Still, the company said that it was committed to advancing the clinical program to the best of its abilities. Scientists have already warned that if ever there was to be a coronavirus vaccine, it wouldn't offer full immunity. In addition, UK Prime Minister Boris Johnson also warned that the vaccine might never be found.
COVID-19 Vaccine: AstraZeneca to supply 400M vaccines by September together with Oxford University
While global expectations for the arrival of the coronavirus vaccine are high, more realistic observers and historical vaccine data have shown that it may take at least a year or more. Heavy research to find the cure for the coronavirus is being performed by more than 80 groups worldwide. Hence, companies like AstraZeneca still have high hopes for the cure to come soon thanks to the most brilliant minds in the world pooling their resources together.
AstraZeneca has said that the production would take place in not just one country, but several. The company thanked the US and UK governments for their "substantial support to accelerate the development and production of the vaccine." They are in talks with the Serum Institute of India and other potential partners to increase the rate of product distribution all around the world.
The company said that it had received financial support of more than $1 billion from the US Biomedical Advanced Research and Development Authority (BARD) for the development, production, and delivery of the said vaccine.
AstraZeneca's chief executive Pascal Soriot described the coronavirus as a "global tragedy" and "a challenge for all humanity."
He added, "We need to defeat the virus together or it will continue to inflict huge personal suffering and leave long-lasting economic and social scars in every country around the world, We are so proud to be collaborating with Oxford University to turn their ground-breaking work into a medicine that can be produced on a global scale."
For more news regarding potential vaccines, we have covered it here on Techtimes about one vaccine that has completed phase one of trials with 100% success, and the company Moderna is the one leading the charge in hopes of finally distributing it around the world later this year or early next year. For more information regarding the topic, click the link here.